澳洋健康
(002172)
| 流通市值：32.52亿 | | | 总市值：32.54亿 |
| 流通股本：7.65亿 | | | 总股本：7.66亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 902,769,818.52 | 452,119,969.79 | 2,009,775,237.99 | 1,501,392,158.94 |
| 营业收入 | 902,769,818.52 | 452,119,969.79 | 2,009,775,237.99 | 1,501,392,158.94 |
| 二、营业总成本 | 854,556,304.75 | 428,104,319.98 | 1,950,426,263.79 | 1,443,960,814.85 |
| 营业成本 | 768,753,039.62 | 383,913,440.39 | 1,740,737,383.15 | 1,295,449,367.85 |
| 税金及附加 | 5,548,766.54 | 2,494,922.69 | 11,087,149.35 | 8,073,208.03 |
| 销售费用 | 17,821,849.7 | 8,585,056.64 | 42,609,496.87 | 32,167,433.29 |
| 管理费用 | 43,928,399.36 | 25,548,561.28 | 124,354,499.52 | 92,868,985.94 |
| 研发费用 | - | - | - | 0 |
| 财务费用 | 18,504,249.53 | 7,562,338.98 | 31,637,734.9 | 15,401,819.74 |
| 其中:利息费用 | 16,243,199.93 | 6,168,699.53 | 39,380,870.42 | 32,794,633.63 |
| 其中:利息收入 | 1,523,883.3 | 1,319,959.91 | 22,504,211.87 | 22,325,884.44 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -350,293.32 | -270,329.68 | -1,312,375.05 | -460,456.68 |
| 资产处置收益 | 6,663.05 | 0 | -59,174.03 | -5,898.86 |
| 信用减值损失(新) | -3,178,620.46 | -577,670.25 | -2,661,266.95 | 4,848,236.73 |
| 其他收益 | 2,294,185.71 | 394,156.99 | 12,292,417.79 | 1,478,419.13 |
| 四、营业利润 | 46,985,448.75 | 23,561,806.87 | 67,608,575.96 | 63,291,644.41 |
| 加:营业外收入 | 3,277,196.95 | 690,333.2 | 866,376.17 | 4,700,827.78 |
| 减:营业外支出 | 3,327,840.55 | 55,419.56 | 3,298,896.95 | 3,161,868.6 |
| 五、利润总额 | 46,934,805.15 | 24,196,720.51 | 65,176,055.18 | 64,830,603.59 |
| 减:所得税费用 | 14,950,763.58 | 5,341,713.4 | 23,935,072.55 | 25,207,774.87 |
| 六、净利润 | 31,984,041.57 | 18,855,007.11 | 41,240,982.63 | 39,622,828.72 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 31,984,041.57 | 18,855,007.11 | 41,240,982.63 | 39,622,828.72 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 31,555,867.42 | 18,499,176.25 | 40,561,915.31 | 38,678,072.35 |
| 少数股东损益 | 428,174.15 | 355,830.86 | 679,067.32 | 944,756.37 |
| 扣除非经常损益后的净利润 | 29,674,235.14 | 17,550,014.69 | 32,576,715.34 | 35,829,457.46 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.04 | 0.02 | 0.05 | 0.05 |
| (二)稀释每股收益 | 0.04 | 0.02 | 0.05 | 0.05 |
| 八、其他综合收益 | - | - | 83,294.05 | - |
| 归属于母公司股东的其他综合收益 | - | - | 83,294.05 | - |
| 九、综合收益总额 | 31,984,041.57 | 18,855,007.11 | 41,324,276.68 | 39,622,828.72 |
| 归属于母公司股东的综合收益总额 | 31,555,867.42 | 18,499,176.25 | 40,645,209.36 | 38,678,072.35 |
| 归属于少数股东的综合收益总额 | 428,174.15 | 355,830.86 | 679,067.32 | 944,756.37 |
| 公告日期 | 2025-08-27 | 2025-04-30 | 2025-04-15 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |